116 related articles for article (PubMed ID: 3493143)
1. 7-Hydroxymethotrexate cytotoxicity and selectivity in a human Burkitt's lymphoma cell line versus human granulocytic progenitor cells: rescue by folinic acid and nucleosides.
Fabre I; Fabre G; Cano JP
Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1247-54. PubMed ID: 3493143
[TBL] [Abstract][Full Text] [Related]
2. Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro.
Fabre I; Fabre G; Goldman ID
Cancer Res; 1984 Aug; 44(8):3190-5. PubMed ID: 6204743
[TBL] [Abstract][Full Text] [Related]
3. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.
Pinedo HM; Zaharko DS; Bull JM; Chabner BA
Cancer Res; 1976 Dec; 36(12):4418-24. PubMed ID: 1087180
[TBL] [Abstract][Full Text] [Related]
4. Interactions between 7-hydroxymethotrexate and folinic acid in RAJI cells, in vitro.
Payet B; Fabre I; Fabre G; Cano JP
Cancer Lett; 1988 Feb; 39(1):45-58. PubMed ID: 3257895
[TBL] [Abstract][Full Text] [Related]
5. Formation of 7-hydroxymethotrexate polyglutamyl derivatives and their cytotoxicity in human chronic myelogenous leukemia cells, in vitro.
Fabre G; Goldman ID
Cancer Res; 1985 Jan; 45(1):80-5. PubMed ID: 2578101
[TBL] [Abstract][Full Text] [Related]
6. Effect of methotrexate on murine bone marrow cells in vitro: evidence of a reversible antiproliferative action.
Strømhaug A; Warren DJ; Slørdal L
Exp Hematol; 1995 May; 23(5):439-43. PubMed ID: 7720815
[TBL] [Abstract][Full Text] [Related]
7. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
Koizumi S; Curt GA; Fine RL; Griffin JD; Chabner BA
J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
[TBL] [Abstract][Full Text] [Related]
8. Further studies on the pharmacologic effects of the 7-hydroxy catabolite of methotrexate in the L1210 murine leukemia cell.
Seither RL; Rape TJ; Goldman ID
Biochem Pharmacol; 1989 Mar; 38(5):815-22. PubMed ID: 2467676
[TBL] [Abstract][Full Text] [Related]
9. In vitro approach to 7-hydroxymethotrexate interaction on methotrexate metabolism as tool of pharmacokinetic study.
Fabre G; Cano JP; Catalin J; Just S
Int J Clin Pharmacol Res; 1983; 3(6):475-84. PubMed ID: 6590470
[TBL] [Abstract][Full Text] [Related]
10. Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.
Goldman ID; Matherly LH
NCI Monogr; 1987; (5):17-26. PubMed ID: 2448654
[TBL] [Abstract][Full Text] [Related]
11. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
Diddens H; Niethammer D; Jackson RC
Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
[TBL] [Abstract][Full Text] [Related]
12. Effects and interaction of 7-hydroxy methotrexate and methotrexate in leukaemic cells ex vivo measured by the thymidylate synthase inhibition assay.
Lingg RM; Hempel G; Rots MG; Van Zantwijk CH; Boos J; Kaspers GJ
Cancer Chemother Pharmacol; 2005 Sep; 56(3):322-7. PubMed ID: 15868145
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of leucovorin reversal of methotrexate cytotoxicity in human MCF-7 breast cancer cells.
Boarman DM; Baram J; Allegra CJ
Biochem Pharmacol; 1990 Dec; 40(12):2651-60. PubMed ID: 2260989
[TBL] [Abstract][Full Text] [Related]
14. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
15. Reversal of methotrexate cytotoxicity to human bone marrow cells and leukemic K562 cells by leucovorin: methotrexate polyglutamates formation as a possible important factor.
Koizumi S; Ueno Y; Ohno I; Ichihara T; Tamaru Y; Matsukawa H
Jpn J Cancer Res; 1990 Nov; 81(11):1162-7. PubMed ID: 1702414
[TBL] [Abstract][Full Text] [Related]
16. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells.
Bowen D; Southerland WM; Johnson DH; Hawkins M; Hughes DE
Cancer Detect Prev; 2000; 24(5):452-8. PubMed ID: 11129987
[TBL] [Abstract][Full Text] [Related]
17. Interactions between 7-hydroxymethotrexate and methotrexate at the cellular level in the Ehrlich ascites tumor in vitro.
Fabre G; Matherly LH; Fabre I; Cano JP; Goldman ID
Cancer Res; 1984 Mar; 44(3):970-5. PubMed ID: 6692419
[TBL] [Abstract][Full Text] [Related]
18. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
Rhee MS; Galivan J; Wright JE; Rosowsky A
Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
Rosenblatt DS; Whitehead VM; Matiaszuk NV; Pottier A; Vuchich MJ; Beaulieu D
Mol Pharmacol; 1982 May; 21(3):718-22. PubMed ID: 6180291
[TBL] [Abstract][Full Text] [Related]
20. Effects of methotrexate on purine and pyrimidine metabolism and cell-kinetic parameters in human malignant lymphoblasts of different lineages.
Bökkerink JP; De Abreu RA; Bakker MA; Hulscher TW; van Baal JM; Schretlen ED; De Bruijn CH
Biochem Pharmacol; 1988 Jun; 37(12):2329-38. PubMed ID: 2455520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
